These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 31473580

  • 1. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
    Fang P, Sun Y, Gu X, Shi M, Bo P, Zhang Z, Bu L.
    Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
    [Abstract] [Full Text] [Related]

  • 2. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP, Lee MC, Foufelle F, Sajan J, Cleland C, Farese RV.
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [Abstract] [Full Text] [Related]

  • 3. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L, Ding X, Wang Y, Gu M, Zhang J, Yan S, Li N, Song Z, Yin J, Lu L, Peng Y.
    Int J Biol Sci; 2019 Mar; 15(13):2815-2829. PubMed ID: 31853220
    [Abstract] [Full Text] [Related]

  • 4. p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes.
    Collins QF, Xiong Y, Lupo EG, Liu HY, Cao W.
    J Biol Chem; 2006 Aug 25; 281(34):24336-44. PubMed ID: 16803882
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effect of baicalin on insulin sensitivity in adipocytes of diet-induced obese mice.
    Fang P, Yu M, Min W, Han S, Shi M, Zhang Z, Bo P.
    Diabetes Res Clin Pract; 2018 May 25; 139():262-271. PubMed ID: 29526684
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional coactivator NT-PGC-1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis.
    Chang JS, Jun HJ, Park M.
    Physiol Rep; 2016 Oct 25; 4(20):. PubMed ID: 27798359
    [Abstract] [Full Text] [Related]

  • 7. Time-restricted feeding attenuates gluconeogenic activity through inhibition of PGC-1α expression and activity.
    She Y, Sun J, Hou P, Fang P, Zhang Z.
    Physiol Behav; 2021 Mar 15; 231():113313. PubMed ID: 33412190
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
    Lee JM, Han HS, Jung YS, Harris RA, Koo SH, Choi HS.
    J Biol Chem; 2018 Aug 24; 293(34):13125-13133. PubMed ID: 29950523
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
    Lee JM, Seo WY, Han HS, Oh KJ, Lee YS, Kim DK, Choi S, Choi BH, Harris RA, Lee CH, Koo SH, Choi HS.
    Diabetes; 2016 Jan 24; 65(1):62-73. PubMed ID: 26340929
    [Abstract] [Full Text] [Related]

  • 12. Baicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway.
    Fang P, Yu M, Zhang L, Wan D, Shi M, Zhu Y, Bo P, Zhang Z.
    Mol Cell Endocrinol; 2017 Jun 15; 448():77-86. PubMed ID: 28359800
    [Abstract] [Full Text] [Related]

  • 13. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.
    Aatsinki SM, Buler M, Salomäki H, Koulu M, Pavek P, Hakkola J.
    Br J Pharmacol; 2014 May 15; 171(9):2351-63. PubMed ID: 24428821
    [Abstract] [Full Text] [Related]

  • 14. Baicalin regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production.
    Xu J, Li Y, Lou M, Xia W, Liu Q, Xie G, Liu L, Liu B, Yang J, Qin M.
    Pharmacol Res; 2018 Oct 15; 136():62-73. PubMed ID: 30144531
    [Abstract] [Full Text] [Related]

  • 15. miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α.
    Fang Z, Li P, Jia W, Jiang T, Wang Z, Xiang Y.
    Int J Mol Med; 2016 Sep 15; 38(3):845-52. PubMed ID: 27432632
    [Abstract] [Full Text] [Related]

  • 16. Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose consumption.
    Fang P, He B, Yu M, Shi M, Zhu Y, Zhang Z, Bo P.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1341-1350. PubMed ID: 30742994
    [Abstract] [Full Text] [Related]

  • 17. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
    Ji LN, Wu S, Fu DQ, Fang SJ, Xie GQ, Fan YS, Bao J.
    J Ethnopharmacol; 2022 Feb 10; 284():114815. PubMed ID: 34763039
    [Abstract] [Full Text] [Related]

  • 18. Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.
    Liang H, Balas B, Tantiwong P, Dube J, Goodpaster BH, O'Doherty RM, DeFronzo RA, Richardson A, Musi N, Ward WF.
    Am J Physiol Endocrinol Metab; 2009 Apr 10; 296(4):E945-54. PubMed ID: 19208857
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin F2α Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity.
    Wang Y, Yan S, Xiao B, Zuo S, Zhang Q, Chen G, Yu Y, Chen D, Liu Q, Liu Y, Shen Y, Yu Y.
    Diabetes; 2018 Sep 10; 67(9):1748-1760. PubMed ID: 29773555
    [Abstract] [Full Text] [Related]

  • 20. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
    Jeong KJ, Kim DY, Quan HY, Jo HK, Kim GW, Chung SH.
    Fitoterapia; 2014 Mar 10; 93():150-62. PubMed ID: 24418657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.